Literature DB >> 17164046

Impact on quality of life of adjuvant therapy for breast cancer.

Halle C F Moore1.   

Abstract

Late toxicities of adjuvant chemotherapy and side effects of endocrine therapy may cause long-term quality-of-life impairments for some individuals who have been treated for breast cancer. Chemotherapy has been associated with durable effects on cognitive function and fatigue and with the induction of menopause. Endocrine therapies can increase menopausal and sexual symptoms and can contribute to weight gain. Overall, however, quality of life is good for the majority of breast cancer survivors who have received adjuvant systemic therapy. Behavioral interventions that target fatigue and sleep disturbance may further enhance quality of life.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17164046     DOI： 10.1007/bf02951424

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


  16 in total

1.  Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women.

Authors:  Timothy J Whelan; Paul E Goss; James N Ingle; Joseph L Pater; Dongsheng Tu; Kathleen Pritchard; Shifang Liu; Lois E Shepherd; Michael Palmer; Nicholas J Robert; Silvana Martino; Hyman B Muss
Journal:  J Clin Oncol       Date:  2005-09-12       Impact factor: 44.544

2.  The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer.

Authors:  Annette L Stanton; Coen A Bernaards; Patricia A Ganz
Journal:  J Natl Cancer Inst       Date:  2005-03-16       Impact factor: 13.506

3.  Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects.

Authors:  Josée Savard; Sébastien Simard; Hans Ivers; Charles M Morin
Journal:  J Clin Oncol       Date:  2005-09-01       Impact factor: 44.544

4.  Effects of weight training on quality of life in recent breast cancer survivors: the Weight Training for Breast Cancer Survivors (WTBS) study.

Authors:  Tetsuya Ohira; Kathryn H Schmitz; Rehana L Ahmed; Douglas Yee
Journal:  Cancer       Date:  2006-05-01       Impact factor: 6.860

5.  Home-based physical activity intervention for breast cancer patients.

Authors:  Bernardine M Pinto; Georita M Frierson; Carolyn Rabin; Joseph J Trunzo; Bess H Marcus
Journal:  J Clin Oncol       Date:  2005-05-20       Impact factor: 44.544

6.  Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.

Authors:  Kristine A Donovan; Brent J Small; Michael A Andrykowski; Frederick A Schmitt; Pamela Munster; Paul B Jacobsen
Journal:  Cancer       Date:  2005-12-01       Impact factor: 6.860

7.  Fatigue in long-term breast carcinoma survivors: a longitudinal investigation.

Authors:  Julienne E Bower; Patricia A Ganz; Katherine A Desmond; Coen Bernaards; Julia H Rowland; Beth E Meyerowitz; Thomas R Belin
Journal:  Cancer       Date:  2006-02-15       Impact factor: 6.860

8.  Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life.

Authors:  Katherine L Byar; Ann M Berger; Suzanne L Bakken; Melissa A Cetak
Journal:  Oncol Nurs Forum       Date:  2006-01-01       Impact factor: 2.172

9.  Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.

Authors:  Nadine Tchen; Helen G Juffs; Fiona P Downie; Qi-Long Yi; Hanxian Hu; Irene Chemerynsky; Mark Clemons; Michael Crump; Paul E Goss; David Warr; Mary E Tweedale; Ian F Tannock
Journal:  J Clin Oncol       Date:  2003-11-15       Impact factor: 44.544

10.  A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.

Authors:  V Jenkins; V Shilling; G Deutsch; D Bloomfield; R Morris; S Allan; H Bishop; N Hodson; S Mitra; G Sadler; E Shah; R Stein; S Whitehead; J Winstanley
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640
View more
  2 in total

1.  Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer.

Authors:  Shoshana M Rosenberg; Anne O'Neill; Karen Sepucha; Kathy D Miller; Chau T Dang; Donald W Northfelt; George W Sledge; Bryan P Schneider; Ann H Partridge
Journal:  JAMA Netw Open       Date:  2022-02-01

2.  Factors associated with quality of life of outpatients with breast cancer and gynecologic cancers and their family caregivers: a controlled study.

Authors:  Abdel W Awadalla; Jude U Ohaeri; Abdullah Gholoum; Ahmed O A Khalid; Hussein M A Hamad; Anila Jacob
Journal:  BMC Cancer       Date:  2007-06-19       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.